Francis deSouza, Illumina’s CEO, says the more powerful model will be able to sequence 20,000 genomes per year; its current machines can do about 7,500. Illumina will start selling the new ...

Illumina CEO Francis deSouza unveils the NovaSeq X Series sequencing platforms. San Diego-based genomics pioneer Illumina on Thursday introduced a new machine that will sequence a human genome in ...

Illumina has created a software patch for the machines. Skip to Main Content. research. patients. ... FDA warns of security vulnerability in Illumina’s DNA sequencing machines. By Matthew Herper ...

Illumina Inc. introduced a new line of gene-sequencing machines that the company says can more than double capacity versus prior sequencers, while reducing the cost per genome. The rollout, which ...

Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

DNA sequencing and bioanalysis machines produced by a California-based medical technology company known as Illumina are susceptible to being compromised by threat actors through the exploitation ...

Genetic sequencing company Illumina has unveiled a new machine it says can sequence the human genome for just $200, Wired reported Sept. 29. It currently costs roughly $600 to sequence an entire ...

Illumina is by far the dominant supplier of sequencing machines to research labs, hospitals and pharmaceutical companies, with a market share of over 75% in the U.S.

Gene sequencing machine maker Illumina on Tuesday forecast 2024 sales from its core segment to decline, a sign that subdued demand for its instruments used in genetic tests could extend further ...

Illumina (ILMN) is a technology company that sells sequencing machines and consumables required for genomic testing. This business saw a dramatic rise in demand during the Covid-19 pandemic.